Issues related to independent pharmacy, including insurance coverage, network, and reimbursement; S. 526, Pharmacy Benefit Transparency Act; H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act.
2025 · 4th Quarter (Oct 1 - Dec 31)
AMERICAN PHARMACIES, INC.
Filed by ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC).
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC)
- Filing UUID
- 7f853023-2b6b-4c36-ba85-e259badb4837
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to independent pharmacy, including Medicare and Medicaid reimbursement; H.R. 1, One Big Beautiful Bill Act; H.R. 4317, Pharmacy Benefit Manager (PBM) Reform Act; S. 882, Patients Before Middlemen (PBM) Act; H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Equitable Community Access to Pharmacist Services (ECAPS) Act; H.R. 2484, Seniors Access to Critical Medications Act; IRA Medicare Drug Price Negotiation program implementation.
Literal federal measure citations: H.R. 1, H.R. 4317, S. 882, H.R. 5031, H.R. 3164, S. 2426, H.R. 2484
TRICARE pharmacy program.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.